63
Growth Score
pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
540029
Vybion, Inc. is a development stage company.
About the Company
Vybion is a development stage company with platform technology for the development of a new drug class called Intrabodies. Their lead candidate for Huntington's and Azheimer's diseases is INT41 an scFv fragment that can alter gain of toxic function in Huntington's disease and block Fyn kinase binding to Tau in Alzheimer's
disease. The Company operates virtually out of Monterey, CA and is focused on completing an IND enabling package for INT41.
